D.E. Shaw & Co’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-804,024
Closed -$85.4M 4689
2014
Q2
$85.4M Buy
804,024
+783,036
+3,731% +$76.8M 0.12% 199
2014
Q1
$1.83M Sell
20,988
-403
-2% -$31.1K ﹤0.01% 2484
2013
Q4
$899K Sell
21,391
-5,723
-21% -$235K ﹤0.01% 3269
2013
Q3
$1.19M Sell
27,114
-19,834
-42% -$821K ﹤0.01% 2880
2013
Q2
$1.6M Buy
+46,948
New +$1.65M ﹤0.01% 2336

D.E. Shaw & Co's FURX Position: Q3 2014 in Review

D.E. Shaw & Co sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 804,024 shares — an estimated $85.4M sold.

D.E. Shaw & Co first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $85.4M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • D.E. Shaw & Co reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • D.E. Shaw & Co sold 804,024 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $85.4M.
  • D.E. Shaw & Co first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • D.E. Shaw & Co's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $85.4M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.